Access cutting-edge ulcerative colitis treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access ulcerative colitis specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ulcerative colitis treatment provided free
The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate any problems. The participants will take capsules of either TAK-279 or placebo for up to 3 months (12 weeks). Then all the participants will receive TAK-279 for the rest of the treatment part of the study (1 year or 52 weeks). During the study,
Sponsor: Takeda
Check if you qualify for this ulcerative colitis clinical trial in Los Angeles, CA
If you're searching for ulcerative colitis treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ulcerative colitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.